Henry Masur, MD
Chief, Critical Care Medicine Department
National Institutes of Health
Bethesda, MD

Research Topics

• PCP
• Prophylaxis of opportunistic infections
  
  
  

Lecture and Writing Topics

• PCP
• Prophylaxis of opportunistic infections
• Management of opportunistic infections
  
  
  

Committees and Organizations

• American Society for Clinical Investigation
• Association of American Physicians
  
  
  

Honors and Awards

• Award for Excellence in Education, NIH
• Director's Award, Clinical Center, NIH
• Special citation, Society of Clinical Care Medicine
• Vice-President, Infectious Diseases Society of America
  
  
  

Education

• Dartmouth University, AB (1968)
• Cornell University, MD (1972)
  
  
  

Selected Publications

1. Kaplan JE, Janoff EN, Masur H. Editorial response: do bacterial pneumonia and Pneumocystis carinii pneumonia accelerate progression of human immunodeficiency virus disease? Clin Infect Dis. 1999;23:544-546.
2. Kovacs JA, Masur H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus. N Engl J Med. 2000;342:1416-1429.
3. Walker RE, Bechtel CM, Natarajian V, Baseler M, Hege KM, Metcalf JA, Stevens R, Hazen A, Blaese RM, Chen CC, Letiman SF, Palensky J, Wittes J, Davey RT, Falloon J, Polis MA, Kovacs JA, Broad DF, Levine BL, Roberts MR, Masur H, Lane HC. Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood. 2000;15;96:467-474.
4. Masur H, Shelhamer J. Pneumocystis pneumonia: miles to go (editorial). Chest. 2000;118:575-577.
5. Bernard GR, Sopko G, Cerra F, Demling R, Edmunds H, Kaplan S, Kessler L, Masur H, Parson P, Shure D, Webb C, Weidemann H, Weinmann G, Williams D. Pulmonary artery catheterization and clinical outcomes: National Heart, Lung, and Blood Institute and Food and Drug Administration Workshop Report. Consensus Statement. JAMA. 2000;17;283:2568-2572.
6. Miller KD, Masur H, Jones EC, Joe GO, Rick ME, Kelly GG, Mican JM, Liu S, Gerber LH, Blackwelder WC, Falloon J, Davey RT, Polis MA, Walker RE, Lane HC, Kovacs JA. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med. 2002;137:17-25.
7. Falloon J, Ait-Khaled M, Thomas DA, Brosgart CL, Eron Jr JJ, Feinberg J, Flanigan TP, Hammer SM, Kraus PW, Murphy R, Torres R, Masur H. HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients. AIDS. 2002;16:387-396.
8. Sklar P, Masur H. HIV infection and cardiovascular disease-is there really a link? N Engl J Med. 2003;349:2065-2067.
9. Larsen HH, Huang L, Kovacs JA, Crothers K, Silcott VA, Morris A, Turner JR, Beard CB, Masur H, Fischer SH. A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis. 2004;189:1679-1683.
10. Benson C, Holmes KK, Pau A, Masur H, Kaplan J. Guidelines for the management of opportunistic infections in patients with HIV infection. CID and MMWR. In press.